K-ras point mutation detection in lung cancer: Comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification

Clinical Chemistry

Volumn 46, Issue 12, 2000, Pages 1929-1938

  Clayton, S J ^a   Scott, F M ^a   Walker, J ^a   Callaghan, K ^a   Haque, K ^a   Liloglou, T ^a   Xinarianos, G ^a   Shawcross, S ^a   Ceuppens, P ^a   Field, J K ^a   Fox, J C ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA;

ALLELE; AMINO ACID ANALYSIS; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE AMPLIFICATION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; LUNG CANCER; MOLECULAR DYNAMICS; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SOMATIC CELL GENETICS; SQUAMOUS CELL CARCINOMA;

EID: 0033638755     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.12.1929     Document Type: Article

References (38)

1. Nucleic acid-based methods for the detection of cancer
2. Cancer
3. How shall we apply the new biology to diagnostics in surgical pathology?
4. Sentinel lymphadenectomy in breast cancer: Identification of sentinel lymph node and detection of metastases
5. The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region
6. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence
7. Detection of bladder cancer recurrence by microsatellite analysis of urine
8. Detection of minimal residual disease: Relevance for diagnosis and treatment of human malignancies
9. Micrometastases and survival in stage II colorectal cancer
10. Thymidylate synthase as a predictor of response
11. Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy
12. Pharmacogenomics: Translating functional genomics into rational therapeutics
13. Molecular abnormalities in lung cancer
14. Selection and validation of new lung cancer markers for the molecular-pathological assessment of individuals with a high risk of developing lung cancer
15. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
16. The ras gene family and human carcinogenesis
17. Molecular detection of early lung cancer
18. The ras gene family in human non-small cell lung cancer
19. K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: A combined analysis of 881 cases
20. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung
21. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer
22. Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma
23. K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer
24. K-ras genotypes and prognosis in non-small-cell lung cancer
25. Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma
26. Methods for detection of point mutations - Performance and quality assessment
27. Sensitive methods for the detection of ras mutations in lung cancer: Some answers, more questions
28. Detection of K-ras mutations in non-small cell lung carcinoma
29. The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system
30. Molecular beacons - Probes that fluoresce upon hybridization
31. Kinetic PCR analysis. Real-time monitoring of DNA amplification reactions
32. Extension of base mispairs by Taq DNA polymerase: Implications for single nucleotide discrimination in PCR
33. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma
34. Detection of low-fraction K-ras mutations in primary lung tumors using a sensitive method
35. K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer
36. Molecular damage in the bronchial epithelium of current and former smokers
37. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer
38. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer